R4 Ballot #1 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: R4 Ballot 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4

Plandefinition-opioidcds-08

Clinical Decision Support Work Group

Maturity Level: N/A

Ballot Status: Informative

Compartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile PlanDefinition.

Generated Narrative with Details

id: opioidcds-08

url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-08

identifier: cdc-opioid-guidance (OFFICIAL)

version: 0.1.0

name: cdc-opioid-08

title: CDC Opioid Prescribing Guideline Recommendation #8

type: ECA Rule (Details : {http://hl7.org/fhir/plan-definition-type code 'eca-rule' = 'ECA Rule', given as 'ECA Rule'})

status: draft

date: 19/03/2018

publisher: Centers for Disease Control and Prevention (CDC)

description: Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.

useContext: ,

jurisdiction: United States of America (Details : {urn:iso:std:iso:3166 code 'US' = 'United States of America', given as 'United States of America'})

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.

topic: Opioid Prescribing (Details )

contributor: , , ,

relatedArtifact: ,

library: Library/opioidcds-recommendation-08

action
title: Existing patient exhibits risk factors for opioid-related harms.
description: Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.
documentation:
trigger:
Conditions
- Kind Description Language Expression
* applicability Check whether the existing patient exhibits risk factors for opioid-related harms, such as concurrent use with benzodiazepine, a history of substance abuse, and/or a average MME greater than 50 mg/day. text/cql Inclusion Criteria
groupingBehavior: visual-group
selectionBehavior: exactly-one
dynamicValue
path: action.description
expression: Get Detail
dynamicValue
path: action.title
expression: Get Summary
dynamicValue
path: action.extension
expression: Get Indicator
Actions
-
*
*
*

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.